Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians.
Muzumdar S, Skudalski L, Sharp K, Waldman RA.
Am J Clin Dermatol. 2022 Jan;23(1):61-67. doi: 10.1007/s40257-021-00646-z. Epub 2021 Dec 2.
[Redness of the skin].
Saib R, Raffray L, Bagny K.
Rev Med Interne. 2024 Mar;45(3):180-182. doi: 10.1016/j.revmed.2024.02.004. Epub 2024 Mar 4.
Erythema Multiforme: Recognition and Management.
Trayes KP, Love G, Studdiford JS.
Am Fam Physician. 2019 Jul 15;100(2):82-88.
An Oral Botanical Supplement Improves Small Intestinal Bacterial Overgrowth (SIBO) and Facial Redness: Results of an Open-Label Clinical Study.
Min M, Nadora D, Chakkalakal M, Afzal N, Subramanyam C, Gahoonia N, Pan A, Thacker S, Nong Y, Chambers CJ, Sivamani RK.
Nutrients. 2024 Sep 18;16(18):3149. doi: 10.3390/nu16183149.
Microbotox for facial redness.
Gaál M.
Int J Dermatol. 2024 May;63(5):553-554. doi: 10.1111/ijd.17114. Epub 2024 Mar 1.
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy.
Lee JS, Kim CY.
Expert Rev Clin Pharmacol. 2022 Aug;15(8):911-919. doi: 10.1080/17512433.2022.2112948. Epub 2022 Aug 18.
Facial and neck erythema associated with dupilumab treatment: A systematic review.
Jo CE, Finstad A, Georgakopoulos JR, Piguet V, Yeung J, Drucker AM.
J Am Acad Dermatol. 2021 May;84(5):1339-1347. doi: 10.1016/j.jaad.2021.01.012. Epub 2021 Jan 8.
Biophysical properties of redness-prone skin in Korean women.
Lee E, Cho C, Ha J.
J Cosmet Dermatol. 2022 Sep;21(9):4035-4041. doi: 10.1111/jocd.14722. Epub 2021 Dec 30.
Topical steroid withdrawal: an emerging clinical problem.
Brookes TS, Barlow R, Mohandas P, Bewley A.
Clin Exp Dermatol. 2023 Aug 25;48(9):1007-1011. doi: 10.1093/ced/llad161.
Immune pathogenesis of idiopathic granulomatous mastitis: from etiology toward therapeutic approaches.
Wang X, He X, Liu J, Zhang H, Wan H, Luo J, Yang J.
Front Immunol. 2024 Mar 11;15:1295759. doi: 10.3389/fimmu.2024.1295759. eCollection 2024.
